MDRTB Then, XMDRTB Now and Then ……… Totally
Journal Title: Journal of Medical Sciences - Year 2016, Vol 19, Issue 1
Abstract
Multidrug-resistant tuberculosis has come up as a separate disease meriting different diagnostic and therapeutic options from conventional tuberculosis. Worldwide there has been a considerable increase in MDRTB cases to 60,000 and less than 5% of them get management as desired by various infectious disease bodies. Another entity titled XMDRTB has of late assumed significant proportion of tuberculosis cases which is steaming into a new health-related inferno. Some sporadic cases of tuberculosis have come up which are completely resistant to all anti-tubercular drugs, that should be an area of concern for all healthcare givers.
Authors and Affiliations
Dr Ajaz Nabi Koul
Keywords
Related Articles
- EP ID EP433684
- DOI -
- Views 67
- Downloads 0
Case of Large Brunners Gland Adenoma
A 23-year-old man was admitted to the surgical ward with a two-month history of epigastric pain, abdominal discomfort, nausea and frequent bouts of vomiting. The Complete Blood Count (CBC) and biochemical investigations...
Transatrial-Transpulmonary correction of TOF with CMR as a definitive diagnostic tool: Replacement of conventional cardioangiography
INTRODUCTION: The objective of this study was to evaluate the associated cardiac anomalies, coronary and pulmonary artery abnormalities and aortopulmonary collaterals in patients of TOF with preoperative CMR and to corre...
Case of Epitheloid Sarcoma Hand
60 year old male presented with an ulceroproliferative growth over wrist joint of right hand with history of rapid increase in size of swelling.Radiology of the lesion did not reveal infiltration of the underlying bone....
Efficacy, Tolerability and Adverse Events of Single-Shot Intra-Articular Hyaluronic Acid Injection in Knee Osteoarthritis
Objective: The clinical experience with single intra-articular hyaluronic acid injection in knee OA is limited. The aim was to assess the therapeutic efficacy, tolerability and adverse events of single-shot intra-articul...
Proinsulin peptide immunotherapy is 'safe'
Dr. Ali and team examined the effect of the peptide in 27 people who had been diagnosed with type 1 diabetes within the previous 100 days. For 6 months, the participants received either shots of the immunotherapy or the...